We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$4.82B
AUM Growth
+$2.15B
Cap. Flow
+$1.73B
Cap. Flow %
35.86%
Top 10 Hldgs %
70.13%
Holding
71
New
9
Increased
19
Reduced
13
Closed
13

Top Buys

Rank Stock Value
1
ROIV icon
Roivant Sciences
ROIV
+$82.8M
2
VYX icon
NCR Voyix
VYX
+$57.3M
3
LBTYA icon
Liberty Global Class A
LBTYA
+$48.3M
4
QDEL icon
QuidelOrtho
QDEL
+$46.2M
5
VTRS icon
Viatris
VTRS
+$41.3M

Top Sells

Rank Stock Value
1
CCJ icon
Cameco
CCJ
+$100M
2
HTZ icon
Hertz
HTZ
+$63.3M
3
NRG icon
NRG Energy
NRG
+$50.8M
4
HOLI
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
+$38.5M
5
FLR icon
Fluor
FLR
+$32.1M

Sector Composition

Rank Sector Weight
1 Healthcare 27.51%
2 Financials 5.41%
3 Technology 4.91%
4 Energy 4.01%
5 Materials 3.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$2.14B 44.38%
+4,500,000
New +$2B
ROIV icon
2
Roivant Sciences
ROIV
$26.2B
$213M 4.43%
19,000,000
+8,500,000
+81% +$82.8M
TEVA icon
3
Teva Pharmaceuticals
TEVA
$41.2B
$190M 3.95%
18,226,601
-773,399
-4% -$7.22M
VTRS icon
4
Viatris
VTRS
$18.9B
$190M 3.95%
17,567,892
+4,317,892
+33% +$41.3M
GLNG icon
5
Golar LNG
GLNG
$5.13B
$150M 3.1%
6,506,757
– –
BGC icon
6
BGC Group
BGC
$4.89B
$144M 3%
20,000,000
– –
COOP
7
DELISTED
Mr. Cooper
COOP
$116M 2.41%
1,785,795
-179,378
-9% -$10.6M
COLL icon
8
Collegium Pharmaceutical
COLL
$956M
$84.9M 1.76%
2,758,253
-416,747
-13% -$10.4M
RNW icon
9
ReNew
RNW
$2.25B
$79.8M 1.66%
10,420,000
+522,574
+5% +$3.22M
QDEL icon
10
QuidelOrtho
QDEL
$838M
$72.2M 1.5%
980,063
+683,637
+231% +$46.2M
PTVE
11
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$69.1M 1.43%
5,039,766
+39,766
+0.8% +$419K
ANIP icon
12
ANI Pharmaceuticals
ANIP
$1.78B
$62M 1.29%
1,125,000
+277,989
+33% +$15.3M
VYX icon
13
NCR Voyix
VYX
$1.14B
$60.7M 1.26%
+3,591,228
New +$57.3M
SSYS icon
14
Stratasys
SSYS
$774M
$60.7M 1.26%
4,250,000
+3,339,367
+367% +$39.1M
FLR icon
15
Fluor
FLR
$7.96B
$59.2M 1.23%
1,510,172
-869,485
-37% -$32.1M
CSTM icon
16
Constellium
CSTM
$3.99B
$58.4M 1.21%
2,924,438
+970,164
+50% +$17M
ADEA icon
17
Adeia
ADEA
$3.11B
$57.5M 1.19%
4,640,009
– –
AIR icon
18
AAR Corp
AIR
$5.76B
$55.9M 1.16%
895,904
-332,518
-27% -$21.4M
DOLE icon
19
Dole
DOLE
$1.32B
$55.7M 1.16%
4,530,940
+788,788
+21% +$9.11M
LBTYA icon
20
Liberty Global Class A
LBTYA
$3.6B
$52.9M 1.1%
+2,979,328
New +$48.3M
KOP icon
21
Koppers
KOP
$969M
$51.6M 1.07%
1,007,341
-131,251
-12% -$5.49M
KNSA icon
22
Kiniksa Pharmaceuticals
KNSA
$5.93B
$51M 1.06%
2,907,501
-169,948
-6% -$2.79M
OFIX icon
23
Orthofix Medical
OFIX
$419M
$49.4M 1.03%
3,665,000
+230,335
+7% +$2.71M
AMRX icon
24
Amneal Pharmaceuticals
AMRX
$5.79B
$48.6M 1.01%
8,000,000
+3,975,500
+99% +$17.7M
HRTX icon
25
Heron Therapeutics
HRTX
$92.9M
$45.4M 0.94%
26,713,503
– –
1
2 3

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $9.55B AUM 31.94% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return

Rubric Capital Management (New York)'s Q4 2023 Portfolio in Review

As of Q4 2023, Rubric Capital Management (New York) held 71 positions worth $4.82B, up 81% from $2.67B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Rubric Capital Management (New York) deployed $1.73B of net new capital in Q4 2023, opening 9 new positions and adding to 19 existing holdings. Its largest new stake was NCR Voyix: 3,591,228 shares worth $60.7M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 36% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Fluor, an estimated $32.1M trimmed.

  • Rubric Capital Management (New York)'s largest Q4 2023 buy was NCR Voyix: 3,591,228 shares worth $60.7M.
  • Rubric Capital Management (New York) added most to Roivant Sciences in Q4 2023, an estimated $82.8M increase.
  • Rubric Capital Management (New York)'s biggest Q4 2023 reduction was Fluor, cutting an estimated $32.1M.
  • Rubric Capital Management (New York) fully exited Cameco in Q4 2023, selling an estimated $100M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 70% of its $4.82B portfolio in Q4 2023.
  • Rubric Capital Management (New York) opened 9 new positions and closed 13 in Q4 2023.
  • Rubric Capital Management (New York)'s portfolio value rose 81% quarter-over-quarter to $4.82B.

Based on Rubric Capital Management (New York)'s 13F filing for Q4 2023, filed 13 Feb 2024.